1. 1) W Collins P, Chalmers E, Hart D, Jennings I, Liesner R, Rangarajan S, Talks K, Williams M, R M Hay C; United Kingdom Haemophilia Centre Doctors’ Organization: Diagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDO. Br J Haematol 162: 758–773, 2013.
2. 2) Franchini M, Castaman G, Coppola A, Santoro C, Zanon E, Di Minno G, Morfini M, Santagostino E, Rocino A; AICE Working Group: Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management. Blood Transfus 13: 498–513, 2015.
3. 3) Hay CR, Brown S, Collins PW, Keeling DM, Liesner R: The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation. Br J Haematol 133: 591–605, 2006.
4. 4) Tengborn L, Astermark J, Ingerslev J, Mäkipernaa A, Tjønnfjord GE, Önundarson PT. Working Group on Acquired Haemophilia of the Nordic Haemophilia Centres: Acquired haemophilia Nordic Guidelines for diagnosis and treatment.
5. 6) Acute pain management: operative or medical procedures and trauma, Part 2. Agency for Health Care Policy and Research. Clin Pharm 11: 391–414, 1992.